{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T16:23:13Z","timestamp":1776874993234,"version":"3.51.2"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["journalofpsychiatricresearch.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Psychiatric Research"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1016\/j.jpsychires.2017.02.007","type":"journal-article","created":{"date-parts":[[2017,2,10]],"date-time":"2017-02-10T23:48:21Z","timestamp":1486770501000},"page":"26-30","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Leukocyte telomere length in Hispanic schizophrenia patients under treatment with olanzapine"],"prefix":"10.1016","volume":"90","author":[{"given":"Nancy","family":"Monroy-Jaramillo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaneth","family":"Rodr\u00edguez-Agudelo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis Carlos","family":"Avi\u00f1a-Cervantes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David L.","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dawn I.","family":"Velligan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Consuelo","family":"Walss-Bass","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpsychires.2017.02.007_bib1","doi-asserted-by":"crossref","first-page":"3","DOI":"10.18632\/aging.100871","article-title":"Markers of cellular senescence. Telomere shortening as a marker of cellular senescence","volume":"8","author":"Bernadotte","year":"2016","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.jpsychires.2017.02.007_bib2","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/j.drudis.2015.06.016","article-title":"Telomerase activation as a possible mechanism of action for psychopharmacological interventions","volume":"20","author":"Bersani","year":"2015","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.jpsychires.2017.02.007_bib4","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1038\/ejhg.2012.303","article-title":"Meta-analysis of telomere length in 19,713 subjects reveals high heritability, stronger maternal inheritance and a paternal age effect","volume":"21","author":"Broer","year":"2013","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.jpsychires.2017.02.007_bib5","series-title":"A\u00a0Systematic Review of Combination and High-dose Atypical Antipsychotic Therapy in Patients with Schizophrenia [Internet]. Appendix 3 Validity of Psychiatric Symptom Scales and Clinical Implications","author":"Canadian Agency for Drugs and Technologies in Health. CADTH","year":"2011"},{"key":"10.1016\/j.jpsychires.2017.02.007_bib6","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1093\/nar\/30.10.e47","article-title":"Telomere measurement by quantitative PCR","volume":"30","author":"Cawthon","year":"2002","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jpsychires.2017.02.007_bib7","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/nrendo.2011.156","article-title":"Metabolic and cardiovascular adverse effects associated with antipsychotic drugs","volume":"8","author":"De Hert","year":"2011","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.jpsychires.2017.02.007_bib8","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1093\/schbul\/sbn169","article-title":"Telomere length and pulse pressure in newly diagnosed, antipsychotic-naive patients with nonaffective psychosis","volume":"35","author":"Fernandez-Egea","year":"2009","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.jpsychires.2017.02.007_bib9","doi-asserted-by":"crossref","first-page":"128","DOI":"10.4103\/0019-5545.82537","article-title":"Drug-emergent metabolic syndrome in patients with schizophrenia receiving atypical (second-generation) antipsychotics","volume":"53","author":"Gautam","year":"2011","journal-title":"Indian J. Psychiatry"},{"key":"10.1016\/j.jpsychires.2017.02.007_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.euroneuro.2014.11.008","article-title":"Antipsychotics-induced metabolic alterations: focus on adipose tissue and molecular mechanisms","volume":"25","author":"Gon\u00e7alves","year":"2015","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.jpsychires.2017.02.007_bib11","doi-asserted-by":"crossref","first-page":"591","DOI":"10.4103\/0253-7613.84979","article-title":"Metabolic syndrome among patients receiving clozapine: a preliminary estimate","volume":"43","author":"Grover","year":"2011","journal-title":"Indian J. Pharmacol."},{"key":"10.1016\/j.jpsychires.2017.02.007_bib12","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1474-9726.2008.00397.x","article-title":"Leukocyte telomeres are longer in African Americans than in whites: the national heart, lung, and blood Institute family heart study and the bogalusa heart study","volume":"7","author":"Hunt","year":"2008","journal-title":"Aging Cell."},{"key":"10.1016\/j.jpsychires.2017.02.007_bib13","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/sj.mp.4002105","article-title":"Rapid telomere erosion in schizophrenia","volume":"13","author":"Kao","year":"2008","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.jpsychires.2017.02.007_bib14","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1192\/bjp.bp.109.076935","article-title":"Treatment with antipsychotics and the risk of diabetes in clinical practice","volume":"197","author":"Kessing","year":"2010","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.jpsychires.2017.02.007_bib15","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.biopsych.2012.10.002","article-title":"Testing the hypothesis of accelerated cerebral white matter aging in schizophrenia and major depression","volume":"73","author":"Kochunov","year":"2013","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jpsychires.2017.02.007_bib16","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/pcn.12260","article-title":"Shortened telomere in unremitted schizophrenia","volume":"69","author":"Kota","year":"2015","journal-title":"Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.jpsychires.2017.02.007_bib17","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1176\/ajp.2006.163.7.1273","article-title":"Prevalence of the metabolic syndrome among patients receiving clozapine","volume":"163","author":"Lamberti","year":"2006","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jpsychires.2017.02.007_bib18","doi-asserted-by":"crossref","first-page":"18553","DOI":"10.1038\/srep18553","article-title":"Association of telomere length and mitochondrial DNA copy number with risperidone treatment response in first-episode antipsychotic-na\u00efve schizophrenia","volume":"5","author":"Li","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jpsychires.2017.02.007_bib19","first-page":"8","article-title":"Metabolic changes associated with antipsychotic use. Prim. Care companion","volume":"6","author":"Lieberman","year":"2004","journal-title":"J.\u00a0Clin. Psychiatry"},{"key":"10.1016\/j.jpsychires.2017.02.007_bib20","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1176\/appi.ajp.2011.11010039","article-title":"The NIMH-CATIE Schizophrenia Study: what did we learn?","volume":"168","author":"Lieberman","year":"2011","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jpsychires.2017.02.007_bib21","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.schres.2015.07.038","article-title":"Shortened leukocyte telomere length in patients with schizophrenia is related to disease status","volume":"168","author":"Lin","year":"2015","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.jpsychires.2017.02.007_bib22","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1002\/mgg3.71","article-title":"Telomere length, family history, and paternal age in schizophrenia","volume":"2","author":"Malaspina","year":"2014","journal-title":"Mol. Genet. Genomic Med."},{"key":"10.1016\/j.jpsychires.2017.02.007_bib23","doi-asserted-by":"crossref","first-page":"227","DOI":"10.4103\/0253-7176.119471","article-title":"Metabolic syndrome in schizophrenia","volume":"35","author":"Malhotra","year":"2013","journal-title":"Indian J. Psycho.l Med."},{"key":"10.1016\/j.jpsychires.2017.02.007_bib24","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.psychres.2011.01.010","article-title":"Does telomere length mediate associations between inbreeding and increased risk for bipolar I disorder and schizophrenia?","volume":"188","author":"Mansour","year":"2011","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.jpsychires.2017.02.007_bib25","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1016\/j.clinthera.2005.12.005","article-title":"Effects of switching from olanzapine to risperidone on the prevalence of the metabolic syndrome in overweight or obese patients with schizophrenia or schizoaffective disorder: analysis of a multicenter, rater-blinded, open-label study","volume":"27","author":"Meyer","year":"2005","journal-title":"Clin. Ther."},{"key":"10.1016\/j.jpsychires.2017.02.007_bib26","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1097\/01.jcp.0000142281.85207.d5","article-title":"The atypical antipsychotic therapy and metabolic issues national survey: practice patterns and knowledge of psychiatrists","volume":"24","author":"Newcomer","year":"2004","journal-title":"J.\u00a0Clin. Psychopharmacol."},{"key":"10.1016\/j.jpsychires.2017.02.007_bib27","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.schres.2013.06.043","article-title":"Longer telomere length in patients with schizophrenia","volume":"149","author":"Nieratschker","year":"2013","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.jpsychires.2017.02.007_bib28","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.schres.2015.04.025","article-title":"Leukocyte telomere length in patients with schizophrenia: a meta-analysis","volume":"165","author":"Polho","year":"2015","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.jpsychires.2017.02.007_bib29","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jpsychires.2016.04.010","article-title":"Accelerated leukocyte telomere erosion in schizophrenia: evidence from the present study and a meta-analysis","volume":"79","author":"Rao","year":"2016","journal-title":"J.\u00a0Psychiatr. Res."},{"key":"10.1016\/j.jpsychires.2017.02.007_bib30","doi-asserted-by":"crossref","first-page":"4607","DOI":"10.1210\/jc.2014-1851","article-title":"Telomere length as a marker of cellular aging is associated with prevalence and progression of metabolic syndrome","volume":"99","author":"R\u00e9v\u00e9sz","year":"2014","journal-title":"J.\u00a0Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jpsychires.2017.02.007_bib31","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1017\/S0033291716000891","article-title":"Depressive and anxiety disorders and short leukocyte telomere length: mediating effects of metabolic stress and lifestyle factors","volume":"46","author":"R\u00e9v\u00e9sz","year":"2016","journal-title":"Psychol. Med."},{"key":"10.1016\/j.jpsychires.2017.02.007_bib32","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.phrs.2015.07.022","article-title":"Metabolic syndrome and obesity among users of second generation antipsychotics: a global challenge for modern psychopharmacology","volume":"101","author":"Rojo","year":"2015","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.jpsychires.2017.02.007_bib33","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1016\/j.jpsychires.2012.07.005","article-title":"History of mental disorders and leukocyte telomere length in late adulthood: the Helsinki Birth Cohort Study (HBCS)","volume":"46","author":"Savolainen","year":"2012","journal-title":"J.\u00a0Psychiatr. Res."},{"key":"10.1016\/j.jpsychires.2017.02.007_bib34","series-title":"Effect of Antipsychotics on Telomere Length in the hippocampus","author":"Toriumi","year":"2014"},{"key":"10.1016\/j.jpsychires.2017.02.007_bib35","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1192\/bjp.198.2.157a","article-title":"Ziprasidone and the relative risk of diabetes","volume":"198","author":"Vanderburg","year":"2011","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.jpsychires.2017.02.007_bib36","doi-asserted-by":"crossref","first-page":"297","DOI":"10.3389\/fnins.2015.00297","article-title":"Metabolic issues in patients affected by schizophrenia: clinical characteristics and medical management","volume":"9","author":"Ventriglio","year":"2015","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.jpsychires.2017.02.007_bib37","first-page":"244","article-title":"Short telomeres in patients with chronic schizophrenia who show a poor response to treatment","volume":"33","author":"Yu","year":"2008","journal-title":"J.\u00a0Psychiatry Neurosci."}],"container-title":["Journal of Psychiatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395616303880?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395616303880?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,4]],"date-time":"2018-09-04T10:57:18Z","timestamp":1536058638000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022395616303880"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":36,"alternative-id":["S0022395616303880"],"URL":"https:\/\/doi.org\/10.1016\/j.jpsychires.2017.02.007","relation":{},"ISSN":["0022-3956"],"issn-type":[{"value":"0022-3956","type":"print"}],"subject":[],"published":{"date-parts":[[2017,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Leukocyte telomere length in Hispanic schizophrenia patients under treatment with olanzapine","name":"articletitle","label":"Article Title"},{"value":"Journal of Psychiatric Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpsychires.2017.02.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}